| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.13 | 0.04 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | -0.27 | 0.05 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.06 |